European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

T Lehner; M Hoelscher; M Clerici; F Gotch; L Pedneault; J Tartaglia; C Gray; J Mestecky; Q Sattentau; J V Wijgert; C Toure; S Osmanov; R E Schmidt; P Debre; M Romaris; A Hoeveler; S Di Fabio

doi:10.1016/j.vaccine.2005.07.009

European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

T Lehner, M Hoelscher, M Clerici, F Gotch, L Pedneault, J Tartaglia, C Gray, J Mestecky, Q Sattentau, J V Wijgert, C Toure, S Osmanov, R E Schmidt, P Debre, M Romaris, A Hoeveler, S Di Fabio

Centre for Host Microbiome Interactions

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The FC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates, (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. (c) 2005 Elsevier Ltd. All rights reserved

Original language	English
Pages (from-to)	5551 - 5556
Number of pages	6
Journal	Vaccine
Volume	23
Issue number	48-49
DOIs	https://doi.org/10.1016/j.vaccine.2005.07.009
Publication status	Published - 1 Dec 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2005.07.009

Cite this

Lehner, T., Hoelscher, M., Clerici, M., Gotch, F., Pedneault, L., Tartaglia, J., Gray, C., Mestecky, J., Sattentau, Q., Wijgert, J. V., Toure, C., Osmanov, S., Schmidt, R. E., Debre, P., Romaris, M., Hoeveler, A., & Di Fabio, S. (2005). European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research. Vaccine, 23(48-49), 5551 - 5556. https://doi.org/10.1016/j.vaccine.2005.07.009

@article{ef7315d000ea4ae7837378dec0b3da99,

title = "European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research",

abstract = "The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The FC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates, (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. (c) 2005 Elsevier Ltd. All rights reserved",

author = "T Lehner and M Hoelscher and M Clerici and F Gotch and L Pedneault and J Tartaglia and C Gray and J Mestecky and Q Sattentau and Wijgert, {J V} and C Toure and S Osmanov and Schmidt, {R E} and P Debre and M Romaris and A Hoeveler and {Di Fabio}, S",

year = "2005",

month = dec,

day = "1",

doi = "10.1016/j.vaccine.2005.07.009",

language = "English",

volume = "23",

pages = "5551 -- 5556",

journal = "Vaccine",

issn = "1873-2518",

publisher = "Elsevier BV",

number = "48-49",

}

Lehner, T, Hoelscher, M, Clerici, M, Gotch, F, Pedneault, L, Tartaglia, J, Gray, C, Mestecky, J, Sattentau, Q, Wijgert, JV, Toure, C, Osmanov, S, Schmidt, RE, Debre, P, Romaris, M, Hoeveler, A & Di Fabio, S 2005, 'European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research', Vaccine, vol. 23, no. 48-49, pp. 5551 - 5556. https://doi.org/10.1016/j.vaccine.2005.07.009

TY - JOUR

T1 - European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

AU - Lehner, T

AU - Hoelscher, M

AU - Clerici, M

AU - Gotch, F

AU - Pedneault, L

AU - Tartaglia, J

AU - Gray, C

AU - Mestecky, J

AU - Sattentau, Q

AU - Wijgert, J V

AU - Toure, C

AU - Osmanov, S

AU - Schmidt, R E

AU - Debre, P

AU - Romaris, M

AU - Hoeveler, A

AU - Di Fabio, S

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The FC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates, (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. (c) 2005 Elsevier Ltd. All rights reserved

AB - The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The FC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates, (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. (c) 2005 Elsevier Ltd. All rights reserved

U2 - 10.1016/j.vaccine.2005.07.009

DO - 10.1016/j.vaccine.2005.07.009

M3 - Article

SN - 1873-2518

VL - 23

SP - 5551

EP - 5556

JO - Vaccine

JF - Vaccine

IS - 48-49

ER -

European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this